Explore evidence

31.4 %The prevalence of polymerase chain reaction-defined SARS-CoV-2 was 31.4% among 277 participants tested in Sindara and Lambaréné, Gabon, from August 2021 to February 2022.

GabonCOVID-19observed August 2021 to February 2022published 2025The American journal of tropical medicine and hygieneeurope_pmcdocument of 10 observations

4.7 %Co-infection of malaria with filaria prevalence was 4.7% among school-aged children in Gabon.

Gabonfilaria · paludismeobserved 2021published 2024Tropical medicine and infectious diseaseeurope_pmcdocument of 8 observationsDOI 10.3390/tropicalmed10010011

90.3 %Day 28 PCR-adjusted adequate clinical and parasitological response (ACPR) was 90.3% (28/31) with 400 mg ferroquine plus 300 mg artefenomel.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 13 observations

Plasmodium falciparum was the only Plasmodium species identified among malaria-infected patients in the study.

Gabonpaludismeobserved 2012published 2014BioMed research internationaleurope_pmcdocument of 6 observationsDOI 10.1155/2014/351281

19.6 %Oral high-risk (HR) HPV prevalence was 19.6% among 61 unvaccinated men who have sex with men (MSM) taking preexposure prophylaxis (PrEP) in France.

Gabonhigh-risk HPVpublished 2019Open forum infectious diseasesPubMeddocument of 10 observations

13.3 timesInfants born from mothers uncertain about taking prophylactic antiretroviral therapy were 13.3 times more likely to be infected by HIV than infants born from mothers certain about taking prophylactic antiretroviral therapy.

GabonVIH/sidapublished 2018International journal of STD & AIDSPubMeddocument of 5 observations

7.3 %7,3 % des patientes étaient séropositives pour le VIH.

GabonVIH/sidaHAL · Unilimdocument of 322 observations

73 %Unidentified strongyles were identified in 73% of the parasite-positive samples.

Gabonunidentified strongylespublished 2021Veterinary worldeurope_pmcdocument of 14 observations

305 patientsA retrospective survey of 305 patients with COVID-19 found that 279 (92%) were not eligible for a hydroxychloroquine clinical trial mainly due to safety concerns caused by health conditions or co-medications.

GabonCOVID-19published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 8 observations

23 %Microscopic prevalence of P. falciparum infection in Dienga was 23% in the recent study (n = 370), compared to 7% ten years earlier (n = 323), p < 0.001.

Gabonpaludismepublished 2016PloS oneeurope_pmcdocument of 9 observations

42 %Infant colonization rate peaked at 42% after 1 month.

GabonStaphylococcus aureuspublished 2014Clinical microbiology and infection : the official publication of the European Society of europe_pmcdocument of 5 observationsDOI 10.1111/1469-0691.12417

80 %More than 80% of patients showed at least 50% reduction of Schistosoma haematobium egg excretion.

Gabonschistosomiasepublished 2013Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument of 4 observationsDOI 10.1093/cid/cis976

7.2 nMThe mean concentration required to inhibit 50% of growth (IC50) of Plasmodium malariae with chloroquine was 7.2 nM.

Gabonpaludismepublished 2025Pathogens (Basel, Switzerland)europe_pmcdocument of 4 observations

The prevalence of chronic HBV infection (HBsAg+) seems better controlled before age 16–18 by females infected vertically or horizontally in areas where genotypes B–E are dominant.

Gabonhépatite Bpublished 2022Viruseseurope_pmcdocument of 11 observations

0.317 kappaThe agreement between declarative and pharmacy visit compliance methods for quantitative adherence was fair, with a Kappa value of 0.317.

GabonVIH/sidapublished 2019African journal of AIDS research : AJAReurope_pmcdocument of 6 observations

68 %The PCR-based corrected cure rate was 68%.

Gabonstrongyloidiasispublished 2025Parasitology researcheurope_pmcdocument of 7 observations

3,699 patientsThe study involved 3699 sickle cell disease patients living in Mali, Senegal, Ivory Coast, Democratic Republic of Congo, Gabon and Cameroon.

Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2024British journal of haematologyeurope_pmcdocument of 10 observations

95 %The specificity of nasal transepithelial potential difference test for the diagnosis of cystic fibrosis was 95%.

Gaboncystic fibrosispublished 1995PubMedOpenAlexdocument of 5 observations

72.7 %Severe anemia was present in 72.7% of severe malaria cases on admission.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 25 observationsDOI 10.1186/s12936-023-04512-7

112 ml/min/1.73 m²The mean estimated glomerular filtration rate (eGFR) was 112 ± 45.3 ml/min/1.73 m² in children with sickle cell disease.

Gabondrépanocytoseobserved 2022published 2024International Journal of Contemporary PediatricsOpenAlexdocument of 3 observationsDOI 10.18203/2349-3291.ijcp20241285

68.43 %The pooled sensitivity of real-time PCR for syphilis diagnosis was 68.43%.

Gabonsyphilispublished 2022Sexually transmitted diseaseseurope_pmcdocument of 6 observations

46.2 %La prévalence des parasites du paludisme à forme asexuée chez les enfants positifs uniquement pour P. falciparum était de 46,2 % dans le groupe APOE Ɛ4 (79 sur 171).

GabonpaludismeHAL · Unilimdocument of 81 observations

20.4 %The seroprevalence of hepatitis C virus in Ogooué-Lolo province was 20.4%.

Gabonhépatite Cpublished 2012PLoS ONEOpenAlexdocument of 7 observationsDOI 10.1371/journal.pone.0042002

0.9 %HPV-11 prevalence among HIV-infected women in Ouagadougou was 0.9%.

GabonVIH/sidaobserved 2009–2010published 2011Acta tropicaeurope_pmcdocument of 8 observations

0.79 AUCSchistosoma haematobium-soluble egg antigen had an area under the curve of 0.79 in urine for diagnosing Schistosoma haematobium infection.

Gabonschistosomiasepublished 2021The Lancet. Microbeeurope_pmcdocument of 7 observationsDOI 10.1016/s2666-5247(21)00150-6